🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareFDA compounding enforcement update — June 2026 guidance document Page 11

FDA compounding enforcement update — June 2026 guidance document

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 336 replies 53,782 viewsPage 11 of 20
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Mar 13, 2024 at 8:07 PM#51

Following on from RegAffairsDC — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

Last edited: Mar 13, 2024 at 9:07 PM
42 17hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 39 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Mar 14, 2024 at 5:30 AM#52
sophie_paris said:
Keep the original post as written when you update it, and add the correction underneath.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

Last edited: Mar 14, 2024 at 8:30 AM
41 16tane_welly, Dr.PathRoch, mona_PHX and 38 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Mar 14, 2024 at 2:53 PM#53
sophie_paris said:
Keep the original post as written when you update it, and add the correction underneath.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

40 15kevin_tulsa, Dr.PainCLE, mike_mealprep and 37 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Mar 15, 2024 at 12:16 AM#54
sophie_paris said:
Keep the original post as written when you update it, and add the correction underneath.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

39 14NurseKim_ATL, paul_denver, TinaHashiRN and 36 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Mar 15, 2024 at 9:39 AM#55

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

38 13BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 35 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register